- AlmirallMedical Affairs Lead Skin Inflammation and CancerMay 2021 - November 2022 (1 year and 6 months)London, UKMedical Lead generating and implementing scientific and medical strategy for products related to the treatment of Actinic Keratosis and Atopic Dermatitis in all phases of their lifecycle. Responsible for internal training of field personnel. Medical input for market access activities such as application for reimbursement (SMC, AWMSG, NCPE), for inclusion of marketed products in formulary and Advanced Budgetary Notification in pre-launch period. Actively influencing global medical strategy and tactics through engagement with global medical affairs for -development and implementation of post launch real world evidence generation programs-pre-launch readiness for a biologic in late phase 3 development. Responsible for ABPI compliance fitness review (non medical signatory).
- TAKEDAMedical Affairs Advisor Immunology Rare DiseasesApril 2019 - April 2021 (2 years)London, UKDevelopment of medical plans, implementation of medical tactics (data dissemination and generation health care professionals' engagement) and strategic medical support of broad immunology cross-functional units (commercial, market access, regulatory and patient services) of the company providing insights, training and data analysis throughout the life cycle of immunology portfolio.
- Shire Pharmaceuticals (acquired by Takeda)Medical Affairs Immunology Manager UKJune 2016 - March 2019 (2 years and 9 months)London, UKDevelopment of medical plans, implementation of medical tactics (data dissemination and generation health care professionals' engagement) and strategic medical support of broad immunology cross-functional units (commercial, market access, regulatory and patient services) of the company providing insights, training and data analysis throughout the life cycle of immunology portfolio.
- Doctor of Philosophy (Ph.D.), ImmunologyUniversité Paul Sabatier (Toulouse III)2004Doctor of Philosophy (Ph.D.), Immunology
- MDSchool of Medicine Université Paul Sabatier (Toulouse France)2000Doctor of Medicine (MD), Clinical Biopathology